3d
MedPage Today on MSNDeciding Whether Multiple Sclerosis Treatment Should Be DiscontinuedObservational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
Christina Applegate discusses her harrowing journey with multiple sclerosis (MS), revealing over 30 hospital visits since her ...
Gabryelle “Gabby” Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center ...
March is Multiple Sclerosis Awareness Month, and a local yoga instructor is hosting a free class this weekend.
4d
Live Science on MSNIn a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...
Multiple sclerosis turned Hollie Amadio's life upside-down, but a chance encounter gave her a new purpose on behalf of the MS ...
1d
GlobalData on MSNTiziana Life Sciences begins dosing in trial of therapy for multiple sclerosisThe trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.
Sanofi (NASDAQ:SNY) said on Tuesday that the US FDA has granted priority review for the regulatory submission of tolebrutinib ...
Columnist Ben Hofmeister shares an important lesson he learned while serving in the Army that applies to the unique care required by MS.
Warriors MS Benefit Auction is this Saturday to continue raising money to help research for treatments and eventually a cure.
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results